Rapid acceleration of diagnostics (radx) program: tech project no 2375 - massively parallel centralized and decentralized ultrafast covid-19INFECTIOUSNESS testing
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00017
- Awardee
-
Flambeau Diagnostics LLC UEI VLZHU9Z7URH3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,000,000
Award facts
- Contract value 91% obligated
-
- $12,000,000.00 Current, with exercised options
- $13,120,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53716, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Definitize Letter Contract | $7,200,000 | |
| Original award | $4,800,000 |
About this award
Flambeau Diagnostics LLC was awarded a firm fixed price definitive contract valued at $13,120,000 by the National Institutes of Health National Heart Lung and Blood Institute to support the RADX Program. The contract calls for Flambeau Diagnostics to provide massively parallel centralized and decentralized ultrafast COVID-19 infectiousness testing in support of the agency's efforts to accelerate diagnostic technologies for COVID-19 under its RADX Program. Work will be performed in Monona, Wisconsin over a one year period ending in September 2021. No set aside designation or major subcontractors were indicated.
Quick answers
Who was awarded contract 75N92020C00017?
75N92020C00017 was awarded to Flambeau Diagnostics LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 30, 2020.
How much is contract 75N92020C00017 worth?
The government has obligated $12,000,000 on 75N92020C00017. Its potential value, with all options, is $13,120,000.
Was contract 75N92020C00017 competed?
The extent of competition for 75N92020C00017 was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award